HOME > Our Company > Corporate Profile > History

History

-1950

1912 10 Taisho Seiyakusho was founded.
1927   Cough suppressant Pablon was launched.
1928 5 Taisho Pharmaceutical Co., Ltd., was established in Tokyo's Bunkyo Ward.
1943 6 Upon the passing of Taisho president Kinujiro Ishii, Teruji Ishii assumed the post.
  7 Head office moved to Tokyo's Toshima Ward.
1946 6 Managing Director Shokichi Uehara assumed post of president.
1948 5 Company's Japanese name was changed.

1951-1970

1955 7 Eagle trademark was adapted.
1957 9 Eye treatment Iris was launched.
1962 3 Lipovitan-D was launched.
1963 1 Omiya Factory was constructed.
  9 Taisho's shares were listed on Second Section of the Tokyo Stock Exchange.
1966 8 Taisho's shares were listed on First Section of the Tokyo Stock Exchange.
1967 8 The Antiphlogistic pain reliever Opyrin Tablet was launched.

1971-1990

1973 5 Vice-President Shoji Uehara assumed post of president.
1974 7 Research Center was constructed on premises of Omiya Factory.
1977 5 Head office moved to new offices.
1978 6 Designated retailer system was implemented.
  8 Taisho Kanpo Ichoyaku (Herbal Stomach Remedy) was launched.
1982 6 President Shoji Uehara assumed post of chairman.
  6 Vice-President Akira Uehara assumed post of president.
1983 3 Former chairman Shokichi Uehara passed away.
  9 Joint venture, Sanofi-Taisho Pharmaceuticals Co., Ltd., was established.
  9 Taisho Pharmaceutical (H.K.) Co., Ltd., was established.
1984 3 Antiulcer agent Solon was launched.
  6 Taisho Pharmaceutical (Taiwan) Co., Ltd., was established.
1985 2 Uehara Memorial Foundation was established.
  3 Shoji Uehara assumed post of chairman of the Proprietary Association of Japan.
  9 Okayama Factory was constructed.
1988 4 The Support Van system, which handles sales information collected through POS cash registers, was developed
  10 Taisho Pharmaceutical California Inc. was established.
  10 Palux injection, a treatment for minor circulatory ailments, was launched.
1990 9 Taisho Pharmaceutical (Malaysia) Sdn. Bhd. was established.
  10 The first stage of remodeling at the Omiya Factory, including Building No. 1 and certain facilities for common use, was completed.

1991-2000

1991 6 Antibiotic Clarith tablets were launched.
1992 8 Taisho Pharmaceuticals (Philippines) Inc. was established.
  10 Taisho celebrated the 80th anniversary of its foundation.
  12 Health drinks Zena F-II and Zena F-III were launched.
1993 6 The Research Center and new Research Laboratory were completed.
  10 The second stage of remodeling at the Omiya Factory, including the automated materials warehouse and the public welfare building, was completed.
1995 1 Pt. Taisho Indonesia was established.
1996 3 Osotspo Taisho Co., Ltd was established.
  8 Former chairman Sae Uehara passed away.
1997 7 Taisho Pharmaceutical Asia (M) SDN. BHD was established.
  8 The third stage of remodeling at the Hanyu Factory was completed.
  8 London branch was established.
  8 Shanghai Taisho Guan Sheng Yuan Co., Ltd. was established.
1998 3 Web site [http://www.taisho.co.jp/] become available.
  7 Taisho Pharmaceutical Logistics Co., Ltd. was established.
  9 Taisho Pharmaceutical (Europe) Ltd. was established.
1999 3 MedWell Taisho Co., Ltd. was established.
  4 Lipovitan D become available in convenience stores, supermarkets and other outlets.
  6 RiUP -the first drug for male-pattern baldness- was launched.
  6 Akira Uehara assumed post of chairman of WSMI.
  7 The fourth stage of remodeling at the Omiya Factory, including the investigational Drug Production Center and the New Synthesis Building were completed.
  12 TAISHO VIETNAM Co., Ltd. was established.
2000 3 Uehara Museum of Modern Art was established.
  3 Insecticides business was terminated.
  4 The fifth stage of remodeling at the Omiya Factory started.
  6 Orthopedic filling paste "Biopex -R" was launched.
  7 Taisho (Australia) Pty. Ltd. was established.
  8 Taisho Beijing Office was established.

2001-

2001 2 Oxicam-derived NSAID "Lorcam" tablets were launched.
  3 Taisho suspended operations at Medwell Taisho.
  3 Taisho's Omiya Factory received ISO14001 certification.
  7 Novel action vitamin D3 formulation "Hornel" tablets were launched.
  8 TAISHO Pharmaceutical R&D USA Inc. was established.
2002 3 Taisho's Hanyu Factory received ISO 14001 certification.
  5 Taisho took over the "VICKS Medicated Drops" from Procter & Gamble.
  5 The fifth stage of remodeling at the Omiya Factory was completed.
  8 Taisho announced a capital and business alliance with Toyama Chemical Co., Ltd.
  10 Second building of Taisho Pharmaceutical's head office is completed.
  10 Taisho Toyama Pharmaceutical Co., Ltd. was established.
2003 3 Taisho's Okayama Factory received ISO 14001 certification.
  7 Mejiro Real Estate Co., Ltd. was established.
  10 Taisho and P&G sign sole distributorship contract for "VICKS VapoRub", a rub-type cold remedy.
2004 3 "Lipovitan D" reaches a 20-billion milestone in total shipments.
  3 Taisho Pharmaceutical realizes zero waste emission at Hanyu Factory.
2005 3 Taisho Pharmaceutical realizes zero waste emission at Omiya Factory.
  4 Release of "RiUP Lady," a minoxidil product.
  7 Launch of "Pabron" and "Taisho Kampo" in Thailand.
  7 Taisho Forges Business and Capital Ties with Yomeishu Seizo.
  8 Yokohama Distribution Center was constructed.
  9 Taisho Active Health Co., Ltd. was established.
2006 3 New product release of Nourish Biboukassai, skincare brand.
  3 Release of exclusive e-commerce site, Taisho Pharmaceutical Online Shopping.

Page Top